5-138257799-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001496.4(GFRA3):āc.625G>Cā(p.Glu209Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,612,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001496.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFRA3 | NM_001496.4 | c.625G>C | p.Glu209Gln | missense_variant | 4/8 | ENST00000274721.8 | NP_001487.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFRA3 | ENST00000274721.8 | c.625G>C | p.Glu209Gln | missense_variant | 4/8 | 1 | NM_001496.4 | ENSP00000274721 | P2 | |
GFRA3 | ENST00000378362.3 | c.532G>C | p.Glu178Gln | missense_variant | 3/7 | 1 | ENSP00000367613 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000409 AC: 1AN: 244574Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133430
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460730Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 726668
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74386
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.625G>C (p.E209Q) alteration is located in exon 4 (coding exon 4) of the GFRA3 gene. This alteration results from a G to C substitution at nucleotide position 625, causing the glutamic acid (E) at amino acid position 209 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at